GUILLERMO

on July 31, 1963.

Barcelona, EspaЯa

DIRECCIÓN:

Particular:       Joan Prim, 88  3-3

08330 Premià of Sea. Spain

Tel: 34-93-754-8212

Mail: iblanco@iconcologia.net

Trabajo:             Unitat de Consell Genètic

Servei of Prevenció i Control of Càncer

Institut Català d’Oncologia

Av Gran Route s/n Km 2.7

08907 L’Hospitalet. Spain

Tel: 34-93-260-7957

Fax: 34-93-260-7956

Mail: iblanco@iconcologia.net

FORMATION ACADÉM ICA:

Bachelor of Medicine and Cirugía, University of Barcelona, 1987

Doctor of Medicine and Cirugía, University Autónoma of Barcelona, 1996

FORMACIÓN POSGRADO

Cirugía General and of the Digestive tract (MIR)

April, 1989 - December, 1993

Hospital of Sant Pau, Barcelona

Visiting Research Associate

University of Nebraska Medical Center

Omaha, Nebraska, USA

Enero 1994 - June, 1996

SITUACIÓN LABOR CURRENT

Coordinador,

Unitat of Consell Genètic.

Servei of Prevenció i Control of Càncer

Hospital Reynals Lasts i

Institut Català d’Oncologia (ICO)

Profesor Associate,

Departamento of Patología and Terapéutica Experimental

University of Barcelona (UB)

Associate Teacher,

Facultad of Sciences of the Health

International university of Catalunya (UIC)

LINES OF INVESTIGACIÓN

Cáncer Hereditary:

molecular Bases of cácner hereditary

Development of new not invasive hardware to identify the risk of suffering cáncer

emotional Impact in Advice Genético in predisposición hereditary to the cáncer

MEMBER OF SOCIETIES CIENTÍ FICAS

Gastrointestinal International Society for Hereditary Tumors (InSiGHT)

Europaean Collaborative Group-Hereditary GI-Cancer

Europaean Society of Human Genetics

Society Española of Genética Humanizes

Group Español of Cáncer Hereditary, SEOM

Society Española of Cirugía

Catalan Society of Cirugía

Academy of Sciences Médicas of Cataluña and Balearics

PRODUCCIÓN CIENTÍ FICA

Author or Coauthor of más of 40 artículos in magazines científicas españolas or international.

Co-publisher of the first book in Spanish on Cáncer Hereditary

Coauthor of Oncoguía on Advice Genético in Cáncer Hereditary

ARTÍ CHOSEN BOTTOMS

<ul>

<li> Blanco I, Bad-tempered And, Llort G. Cáncer Colorrectal Hereditario. Psicooncología, 2005; 2:213-218.

</li>

<li> González M, Blanco I, Bayes R. Difficulty in the comunicación of the risk of suffering cáncer hereditarily. Psicooncología, 2005; 2:285-292.

</li>

<li> Bad-tempered And, Yagüe C, Schiaffino A, Llort G, Blanco I. Información,  percepción of risk and anxiety before receiving advice genético in predisposición hereditary to cáncer. Enfermería Clínica, 2006; 16 (3):112-8.

</li>

<li> Parés D, Pear M, González G, Paschal M, Blanco I. Familiar Poliposis adenomatosa. Gastroeneterologia and Hepatologia, 2006; 29:625-35

</li>

<li> Dark-haired person V. Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I. Gonzalez S, I Wink And, Capella G, Canzian F. Polymorphisms in genes of nucleotide and basic excision repair: risk and prognosis of colorectal cancer. Clin Cancer Animal; 2006; 12:2101-2108

</li>

<li> You Give birth, D.; Garcia-Ruiz, A.; Biondo, S.; Target, I.; Llort, G.; Arriol, E.; Goose, J.; Del Rio, C.; Osorio, A.; Navarrese, M.; Marti-Rague, J.; Jaurrieta, And. Current status of follow-up of the upper digestive tract in familial adenomatous polyposis. Gastroenterol Hepatol, 2006; 29:15-21

</li>

<li> Chimenos-Kustner E, Paschal M, Blanco I, Finestres F. Hereditary familial polyposis and Gardner’s syndrome: contribution of the odontostomatology examination in its diagnosis and to case description. Oral Med Patol. Oral Cir. Mouth, 2006; 10:402-409

</li>

<li> González S, Blanco I, Fields Or, Julia M, Reyes J, Llompart A, Head E, Germà JR, Workshop To, Capellá G. Founder mutation in familial adenomatous polyposis (FAP) in the Balearic Islands. Cancer Genetics and Cytogenetics, 2005, 158:70–74

</li>

<li> Alazzouzi H, On Sunday And, González S, Blanco I, Armengol M, Espín And, Plaja A, Schwartz S, Capella G, Schwartz S Jr. Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. Molecular Human Genetics, 2005, Vol. 14, No. 2 235–239

</li>

<li> Menéndez M, González S, Blanco I, Guinó And, Peris M, Hairstyle MA, Capellá G, Dark-haired person V, for the Bellvitge Colorectal Cancer Study Group. Colorectal Cancer risk and the APC D1822V variant. Int J Cancer. 2004 October 20; 112 (1):161-3

</li>

<li> Gil F, Méndez I, Sirgo A, Llort G, Blanco I, Cortés-Funes H. Perception of breast cancer risk and surveillance behaviors of women with family history of breast cancer: To brief report on to Spanish cohort. Psycho-oncology 2003; 12:1-7

</li>

<li> Llort G, Yagüe C, Peris M, Blanco I, Germà JR, Bleats To, Alvarez M. Low Frequency of recurrent BRCA1 and BRCA2 mutations in Spain. Human Mutation 2002; 19:307

</li>

<li> Palicio M, Balmaña J, Gonzalez S, Blanco I, Marcuello E, Peinado MA, Julià G, Germà JR, Brunet J, Lopez Lopez JJ, Capellà G. Spanish Families lacking one Amsterdam Criteria harbor the majority of MLH1 gene mutations detected. J Med Genetics 2002; 39:E29

</li>

<li> Balmaña J, Brunet J, Pericay C, Capella G, Hairstyle MA, Blanco I, López JJ, Marcuello E. What is hereditary odd number - polyposis colorectal cancer syndrome?. Rev Oncología 2000; 2:191-201

</li>

<li> Palicio M, Blanco I, Tórtola S, González I, Marcuello E, Brunet J, Gonzalez-Aguilera JJ, Hairstyle MA, Capella G. Intron Splice acceptor site polymorphism in the hMSH2 gene in sporadic and familial colorectal cancer. British Journal of Cancer 2000; 82:535-537

</li>

<li> Blanco I, Kawatsu R, Harrison K, Leichner P, Augustine S, Baranowska-Kortylewicz J, Tempered M, Colcher D.  Anti-idiotypic response against murine monoclonal antibodies reactivates with tumor - associated TAG-72.  J Clin Immunol  1997; 17:96-106

</li>

<li> Guillaumes S, Blanco I, Villanueva A, Sans MD, Key P, Chabas A, Farre A, Lluis F.  Chloroquine stabilizes pancreatic lysosomes and improves survival of mice with diet-induced pancreatitis.  Pancreas 1997; 14:262-266. </li>

</ul>

</td>

</tr>

</table>